All In MedTech

FDA Clearance Tracker · P150011

PERCEVAL SUTURELESS HEART VALVE

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Jan 8, 2016 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Jan 8, 2016

Approved

Time to decision

312 days

Received Mar 2, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P150011
Device name
PERCEVAL SUTURELESS HEART VALVE
Applicant
Corcym S.r.l.
Applicant location
Saluggia
Received
Mar 2, 2015
Decided
Jan 8, 2016
Decision
Approved
Supplements
34 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

Approval for the Perceval Sutureless Heart Valve. This device is indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic aortic valves.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LWR. The earliest in FDA's data is P790007, decided Nov 15, 1979.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Corcym S.r.l.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.